Jones Michael L 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Jones Michael L
Exec. Director, Finance - PAO
Transactions
- Exercise/Conversion
Common Stock
2022-03-01$4.73/sh+2,300$10,879→ 13,498 total - Sale
Common Stock
2022-03-01$17.20/sh−2,300$39,560→ 11,198 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2022-03-01−2,300→ 0 totalExercise: $4.73From: 2013-03-01Exp: 2022-03-01→ Common Stock (2,300 underlying)